TrialBMC pregnancy and childbirth2016

A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.

Amat Bah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.